Discover and read the best of Twitter Threads about #FDAVoices
Most recents (3)
In our ongoing response to the #COVID19 pandemic, we’ve taken several actions. Here’s our update: fda.gov/news-events/pr… 
We’ve updated our FDA COVID-19 Response At-A-Glance Summary, which provides a quick look at facts, figures and highlights on the FDA's response efforts. fda.gov/media/137005/d…
The FDA issued an Emergency Use Authorization (EUA) to Quidel for its QuickVue At-Home #COVID19 Test for at-home use with a prescription.
Here’s a look at some of the FDA’s latest activities in our ongoing response to the #COVID19 pandemic. fda.gov/news-events/pr…
We posted a new #FDAInsight podcast with @AnandShahFDA, and Dr. Peter Marks, Director of @FDACBER, discussing the upcoming Vaccines and Related Biological Products Advisory Committee meeting on Oct. 22, 2020. fda.gov/news-events/fd…
In a new #FDAVoices, “FDA’s Vaccines and Related Biological Products Advisory Committee and its Role in Advising the Agency on COVID-19 Vaccines,” Dr. Peter Marks highlights the value of transparency.. fda.gov/news-events/fd…
One of the agency’s highest priorities is ensuring the quality, safety and effectiveness of vaccines. This deep and abiding commitment is something that we consider essential to engendering the public’s trust in vaccines. #FDAVoices #FDAVaccineFacts fda.gov/news-events/fd…
Vaccines are one of the most significant public health interventions ever implemented. They have been largely responsible for the dramatic reduction in serious adverse consequences and death related to infectious diseases
FDA is committed to making decisions regarding the authorization or approval of #COVID19 vaccines that are guided by science and data & we are committed to expediting the development of COVID-19 vaccines, but not at the expense of sound science and decision making.
